Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The application of MSC-derived secretome has been studied towards different pathologies by counteracting inflammation while inducing tissue regeneration namely in lung, hepatic and brain tissues.”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [160]
In the citing paper
“Nevertheless, this cell-free approach has also been reported with beneficial effects for other pathologies, including bone tissue, cardiovascular, intestinal and renal diseases [158], [159], [160], [161], [162], [163], [164], [165], [166], [167], [168], [169], [170] (Table 2).”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [160]
Citations
Cites
Bone marrow cells regenerate infarcted myocardium
Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D. M., et al. (2001) · Nature · doi:10.1038/35070587 · Cited by 5,155
Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart
Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002) · Circulation · doi:10.1161/hc0102.101442 · Cited by 2,234
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells
Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., Entman, M. L., Michael, L. H., Hirschi, K. K., & Goodell, M. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12150 · Cited by 1,960
Mangi, A. A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J. S., & Dzau, V. J. (2003) · Nature Medicine · doi:10.1038/nm912 · Cited by 1,509
Self-citationKajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
Nygren, J. M., Jovinge, S., Breitbach, M., Säwén, P., Röll, W., Hescheler, J., Taneera, J., Fleischmann, B. K., & Jacobsen, S. E. W. (2004) · Nature Medicine · doi:10.1038/nm1040 · Cited by 1,037
Friedrich, J. O., Apstein, C. S., & Ingwall, J. S. (1995) · Circulation · doi:10.1161/01.cir.92.12.3527 · Cited by 43
Self-citation
Research works printed but not linked: 3
- Tomita, S. et al. Circulation 100 (19 Suppl), II247–56 (1999).
- Gnecchi, M. et al. Circulation 110 (17 Suppl), III249 (2004).
- Kajstura, J. et al. Lab. Invest. 74, 86–107 (1996).
Cited by
Items 401–500 of 1,000
Bhang, S. H., Cho, S., Lim, J. M., Kang, J. M., Lee, T., Yang, H. S., Song, Y. S., Park, M. H., Kim, H.-S., Yoo, K., et al. (2009) · Stem Cells · doi:10.1002/stem.115 · Cited by 84
Noda, S., Kawashima, N., Yamamoto, M., Hashimoto, K., Nara, K., Sekiya, I., & Okiji, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-41741-w · Cited by 78
Zhou, H., Li, X., Yin, Y., He, X., An, Y., Tian, B., Hong, Y., Wu, L., & Chen, F. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01614-w · Cited by 82
van Laake, L. W., Passier, R., den Ouden, K., Schreurs, C., Monshouwer-Kloots, J., Ward-van Oostwaard, D., van Echteld, C. J., Doevendans, P. A., & Mummery, C. L. (2009) · Stem Cell Research · doi:10.1016/j.scr.2009.05.004 · Cited by 78
Genomic Profiling of Mesenchymal Stem Cells
Menicanin, D., Bartold, P. M., Zannettino, A. C. W., & Gronthos, S. (2009) · Stem Cell Reviews and Reports · doi:10.1007/s12015-009-9056-2 · Cited by 85
Guijarro, D., Lebrin, M., Lairez, O., Bourin, P., Piriou, N., Pozzo, J., Lande, G., Berry, M., Tourneau, T. L., Cussac, D., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.016 · Cited by 78
“Preliminary evidence of the efficacy of MSC injection for treatment of acute and chronic myocardial infarction has been observed in both animal models and early clinical trials (1-4), but improvements in symptoms, functional status, or ejection fraction (EF) have not been achieved in recent placebo-controlled clinical…”
Pávó, N., Charwat, S., Nyolczas, N., András, J., Murlasits, Z., Bergler-Klein, J. K., Nikfardjam, M., Benedek, I., Benedek, T., Pavo, I. J., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.06.016 · Cited by 77
Wu, D., Qin, H., Wang, Z., Yu, M., Liu, Z., Peng, H. F., Liang, L., Zhang, C., & Wei, X. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.829136 · Cited by 80
“Furthermore, the stimulation of localized healing by MSCs involves paracrine mechanisms (Gnecchi et al., 2005; Caplan and Correa, 2011), and the application of sEVs may overcome these limitations.”
BackgroundNarita, T., Shintani, Y., Ikebe, C., Kaneko, M., Campbell, N. G. S., Coppen, S. R., Uppal, R., Sawa, Y., Yashiro, K., & Suzuki, K. (2013) · Molecular Therapy · doi:10.1038/mt.2013.9 · Cited by 80
Effects of transplanted bone marrow mesenchymal stem cells on the irradiated intestine of mice
Zhang, J., Gong, J., Zhang, W., Zhu, W., & Li, J. (2008) · Journal of Biomedical Science · doi:10.1007/s11373-008-9256-9 · Cited by 78
“[46] demonstrated that the paracrine action of implanted MSCs could significantly prevent apoptosis of cardiomyocytes after myocardial infarction.”
BackgroundShabbir, A., Zisa, D. C., Leiker, M., Johnston, C., Lin, H., & Lee, T. (2009) · Transplantation · doi:10.1097/tp.0b013e3181a1719b · Cited by 83
“Indeed, the cardiovascular therapeutic effects of MSCs have been largely attributed to their trophic actions (39, 40), although the effective tropic factor(s) remains to be identified.”
BackgroundShen, L., Zeng, W., Wu, Y., Hou, C.-L., Chen, W., Yang, M., Li, L., Zhang, Y., & Zhu, C. (2013) · Cell Transplantation · doi:10.3727/096368912x657495 · Cited by 78
Kim, S., Lee, D.-W., Yu, L. H., Zhang, H., Kim, C. E., Kim, J., Park, T., Cha, K., Seo, S., Roh, M.-S., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs224 · Cited by 77
Huang, B., Qian, J., Ma, J., Huang, Z., Shen, Y., Chen, X., Sun, A., Ge, J., & Chen, H. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt410 · Cited by 77
“Consistent with previous references [46,47], our study showed that MSCs contribute to the angiogenesis and anti-apoptosis, which may be partly due to the MSC-dependent paracrine mechanism and their potential for trans-differentiation [48-51].”
ResultStem Cell Factor Deficiency Is Vasculoprotective
Wang, C., Anderson, N. M., Li, S., Szmitko, P. E., Cherng, W., Fedak, P. W. M., Fazel, S. S., Li, R., Yau, T. M., Weisel, R. D., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000243210.79654.fd · Cited by 77
He, A., Jiang, Y. Y., Gui, C., Sun, Y., Li, J., & Wang, J. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70094-7 · Cited by 77
“It has been reported (17,18) that MSCs provide protection by paracrine mechanisms involving release of a wide array of cytokines (such as vascular endothelial growth factor, hepatocyte growth factor and insulin-like growth factor-1) that exert their effects on surrounding cells.”
BackgroundMesenchymal stem cells (MSCs) as skeletal therapeutics–an update
Saeed, H., Ahsan, M., Saleem, Z., Iqtedar, M., Islam, M. F., Danish, Z., & Khan, A. M. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0254-3 · Cited by 81
“Presumably, spatial and temporal release of these soluble factors is influenced by injured tissue microenvironment [49, 50].”
BackgroundFeygin, J., Mansoor, A., Eckman, P., Swingen, C., & Zhang, J. J. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00242.2007 · Cited by 76
“Both in vitro and in vivo animal models of postinfarction ventricular remodeling have revealed that MSC transplantation is associated with a significant antiapoptosis effect that results from cytokine release by stem cells (8, 9, 35).”
BackgroundLee, E. S. M., Chan, J. K. Y., Shuter, B., Tan, L. G., Chong, M. S. K., Ramachandra, D. L., Dawe, G. S., Ding, J., Teoh, S. H., Beuf, O., et al. (2009) · Stem Cells · doi:10.1002/stem.112 · Cited by 75
Henning, R. J. (2010) · Future Cardiology · doi:10.2217/fca.10.109 · Cited by 83
“Rather, bone marrow cell paracrine actions with the release of biologically active proteins, appear to be the mechanism by which bone marrow cells limit myocardial damage and improve heart function [33,34].”
BackgroundRationale of Mesenchymal Stem Cell Therapy in Kidney Injury
Cantaluppi, V., Biancone, L., Quercia, A. D., Deregibus, M. C., Segoloni, G., & Camussi, G. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.05.027 · Cited by 79
Ghanem, A., Steingen, C., Brenig, F., Funcke, F., Bai, Z.-Y., Hall, C. S., Chin, C. T., Nickenig, G., Bloch, W., & Tiemann, K. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.06.008 · Cited by 75
“Although the underlying mechanisms are a matter of debate, engraftment of MSCs into ischemicmyocardial tissue and their consecutive paracrine effects are thought to substantially attenuate morphologic and functional post-infarction remodelling [2].”
BackgroundHenning, R. J., Burgos, J. D., Vasko, M., Alvarado, F., Sanberg, C. D., Sanberg, P. R., & Morgan, M. B. (2007) · Cell Transplantation · doi:10.3727/096368907783338299 · Cited by 75
Wiest, E. F., & Zubair, A. C. (2020) · Cytotherapy · doi:10.1016/j.jcyt.2020.04.040 · Cited by 79
Man, K., Brunet, M. Y., Fernández‐Rhodes, M., Williams, S., Heaney, L. M., Gethings, L. A., Federici, A., Davies, O. G., Hoey, D. A., & Cox, S. C. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12118 · Cited by 79
“The beneficial effects once attributed to cells, are now thought to be partially due to the paracrine factors delivered by EVs (Gnecchi et al., 2005; Xin et al., 2014).”
BackgroundPaul, J., Coulombe, K. L. K., Tóth, P. T., Zhang, Y., Marsboom, G., Bindokas, V. P., Smith, D. W., Murry, C. E., & Rehman, J. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.09.005 · Cited by 78
“The currently proposed mechanisms of how MSCs promote angiogenesis are thought to involve the release of angiogenic growth factors [12,13] and stabilization of vascular networks through direct contact.”
Wang, K., Xu, L., Rui, Y., Huang, S., Lin, S., Xiong, J., Li, Y., Lee, W., & Li, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120593 · Cited by 75
Stem Cells for Myocardial Repair With Use of a Transarterial Catheter
Wang, X., Jameel, M. N., Li, Q., Mansoor, A., Xiong, Q., Swingen, C., Panetta, C. J., & Zhang, J. J. (2009) · Circulation · doi:10.1161/circulationaha.109.885236 · Cited by 75
Gao, X., Song, L., Shen, K., Wang, H., Qian, M., Niu, W., & Qin, X. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.03.004 · Cited by 77
“The transplantation of MSCs has been shown to improve the repair of infarcted hearts (Gnecchi et al., 2005) and skin wounds (Liu et al.”
BackgroundZhang, Y., Liao, S.-Y., Yang, M., Liang, X., Poon, M.-W., Wong, C., Wang, J., Zhou, Z., Cheong, S.-K., Lee, C. N., et al. (2012) · Cell Transplantation · doi:10.3727/096368912x653020 · Cited by 73
“Prior studies (9,17,31) have suggested that paracine effects rather than de novo vascular regeneration of MSCs may play a more important role in vascular repair and protection.”
BackgroundStem cell secretome, regeneration, and clinical translation: a narrative review
Gwam, C., Mohammed, N., & Ma, X. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5030 · Cited by 72
“, who revealed that MSCs mediated their therapeutic effects by the secretion and release of trophic molecules known as secretomes (17).”
BackgroundChen, S., Chen, Z., Lin, Y.-H., Chen, S.-H., Chou, P., Kao, H., & Lin, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212373 · Cited by 72
Suhr, F., Delhasse, Y., Bungartz, G., Schmidt, A., Pfannkuche, K., & Bloch, W. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.05.010 · Cited by 78
“This report identifies how hBMSCs change proliferation, migration, survival and, in combination with the work of others, also paracrine activity (Gnecchi et al., 2005) and proteolytic activity in response to mechanical stress (Kasper et al.”
BackgroundInfluentialHynes, B. G., Kumar, A. H. S., O’Sullivan, J., Büneker, C. K., Leblond, A., Weiss, S., Schmeckpeper, J., Martin, K., & Caplice, N. M. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr435 · Cited by 72
Park, H., Park, H., Mun, D., Kang, J., Kim, H., Kim, M. S., Cui, S., Lee, S., & Joung, B. (2018) · Yonsei Medical Journal · doi:10.3349/ymj.2018.59.6.736 · Cited by 75
“Under hypoxic conditions, genetically modified bone marrow-derived MSCs overexpressing Akt1 have been found to release paracrine factors that exert cytoprotective effects on cardiomyocytes exposed to hypoxia.(15) Another study of the helpful byproduct effects of MSCs reported the release of cytokines from bone marrow…”
BackgroundKrause, U., Harter, C., Seckinger, A., Wolf, D., Reinhard, A., Bea, F., Dengler, T., Hardt, S., Ho, A., Katus, H. A., et al. (2007) · Stem Cells and Development · doi:10.1089/scd.2006.0089 · Cited by 70
Vilas‐Boas, F., Feitos, G. S., Soares, M. B. P., Mota, A., Pinho‐Filho, J. A., Almeida, A. J. G., Andrade, M. V. S., de CARVALHO, H. G., Dourado-Oliveira, A., & Ribeiro‐dos‐Santos, R. (2006) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2006001500014 · Cited by 71
Mesenchymal Stem Cells for the Treatment of Heart Failure
Ohnishi, S., Ohgushi, H., Kitamura, S., & Nagaya, N. (2007) · International Journal of Hematology · doi:10.1532/ijh97.07041 · Cited by 76
“An interesting observation is that administration of conditioned medium obtained from MSC culture exerted cytoprotective effects on the myocardium in an animal model of myocardial infarction [ 45 ].”
BackgroundBone Marrow-Derived B Cells Preserve Ventricular Function After Acute Myocardial Infarction
Goodchild, T. T., Robinson, K. A., Pang, W., Tondato, F. J., Cui, J., Arrington, J., Godwin, L., Ungs, M., Carlesso, N., Weich, N. S., et al. (2009) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2009.08.010 · Cited by 76
Pederiva, F., Ghionzoli, M., Pierro, A., Coppi, P. D., & Tovar, J. A. (2012) · Cell Transplantation · doi:10.3727/096368912x657756 · Cited by 71
“Despite the minimal indication of engraftment, the main therapeutic effect produced by AFS cells seems to be mediated by paracrine mechanisms elicited through trophic mediators (5,9,14,32,36,37), as evident by the coculture experiments.”
BackgroundSarkar, D., Ankrum, J. A., Teo, G. S. L., Carman, C. V., & Karp, J. M. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.036 · Cited by 70
Viola, M., de Jager, S. C. A., & Sluijter, J. P. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157831 · Cited by 70
Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny
Behfar, A., & Terzic, A. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0429 · Cited by 70
“Paracrine secretion, transdifferentiation, and/or myocardial fusion have all been proposed as potential contributors to an increase in the population of viable cardiomyocytes in the disease setting”
BackgroundGene-modified Mesenchymal Stem Cells Protect Against Radiation-induced Lung Injury
Xue, J., Li, X., Lü, Y., Gan, L., Zhou, L., Wang, Y., Lan, J., Liu, S., Sun, L. P., Li, J., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2012.183 · Cited by 73
Xie, X., Sun, A., Zhu, W., Huang, Z., Hu, X., Jia, J., Zou, Y., & Ge, J. (2011) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.226.29 · Cited by 70
Stretching the limits: Stem cells in regeneration science
Stocum, D. L., & Zupanc, G. K. H. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21774 · Cited by 75
Cardioprotection by Vanadium Compounds Targeting Akt-Mediated Signaling
Bhuiyan, M. S., & Fukunaga, K. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09r01cr · Cited by 70
Extracellular vesicles and their roles in stem cell biology
Hur, Y. H., Cerione, R. A., & Antonyak, M. A. (2019) · Stem Cells · doi:10.1002/stem.3140 · Cited by 70
“The same conditioned medium was also shown to limit infarct size and improve ventricular function in rat models of myocardial infarction to a similar extent as injecting MSCs.29,30 Similar benefits were achieved when using the conditioned medium from MSCs to treat other disease models, such as lung ischemia-reperfusio…”
BackgroundPelacho, B., Nakamura, Y., Zhang, J. J., Ross, J., Heremans, Y., Nelson-Holte, M. H., Lemke, B., Hagenbrock, J., Jiang, Y., Prósper, F., et al. (2007) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.7 · Cited by 69
“…the beneficial effects of the cells on neovascularization may have protected the viable myocardium at risk, some of the protection could also be due to a direct survival effect on cardiomyocytes, a mechanism previously shown by others to be important for limiting scar size (Gnecchi et al., 2005).”
BackgroundSecretome of Peripheral Blood Mononuclear Cells Enhances Wound Healing
Mildner, M., Hacker, S., Haider, T. T., Gschwandtner, M., Werba, G., Barresi, C., Zimmermann, M., Golabi, B., Tschachler, E., & Ankersmit, H. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060103 · Cited by 69
“Many of the regenerative effects seen after administration of stem cells were shown to be rather mediated via a paracrine signaling than by direct cellular interactions [14,15].”
BackgroundZhao, L., Hu, C., Zhang, P., Jiang, H., & Chen, J. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14035 · Cited by 69
“cytokine genes or antiapoptotic genes significantly improved their survival rate in injured tissues.(46,47) Heme oxygenase‐1 (HO‐1), a stress‐inducible enzyme that can catalyze the pro‐oxidant heme into biliverdin, CO and free‐iron, exerted powerful antioxidant effects.”
BackgroundAdult stem cells for cardiac tissue engineering
Martinez, E. C., & Kofidis, T. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.08.009 · Cited by 70
“The paracrine hypothesis of stem cell action has been widely supported by evidence and it has been proposed that a substantial portion of the beneficial effects of MSC implantation is attributable to cardioprotection that leads to repair of ischemic myocardium rather than de novo regeneration by cardiomyogenic differe…”
BackgroundMesenchymal Stem Cells in Cardiology
White, I. A., Sanina, C., Balkan, W., & Hare, J. M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3584-0_4 · Cited by 71
“were the first to demonstrate that genetic modification of MSCs to over-express the anti-apoptotic transcription factor Akt, resulted in a greater resistance to apoptosis both in vitro and in vivo and lead to an increase in cardiac function in a rodent model of MI[132, 133].”
Adipose-derived Mesenchymal Stem Cells and Their Reparative Potential in Ischemic Heart Disease
Badimón, L., Oñate, B., & Vilahur, G. (2015) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2015.02.025 · Cited by 82
“Another important function of ADSCs related to ischemic heart disease is derived from their angiogenic potential.(52,109) Because ADSCs secrete a large number of proangiogenic cytokines and cytoprotective factors, they are an ideal cellular source for angiogenic therapy and apoptosis inhibition.”
BackgroundScheibe, F., Klein, O., Klose, J., & Priller, J. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9798-2 · Cited by 71
Kim, C. H., Lee, J. H., Won, J.-H., & Cho, M. K. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.6.726 · Cited by 73
“Recent studies have reported that implanted MSCs accelerate the restoration of damaged tissue (15-17).”
BackgroundDoyle, B. J., Sorajja, P., Hynes, B. G., Kumar, A. H. S., Araoz, P. A., Stalboerger, P. G., Miller, D. V., Reed, C., Schmeckpeper, J., Wang, S., et al. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0214 · Cited by 72
Mayourian, J., Cashman, T. J., Ceholski, D. K., Johnson, B. V., Sachs, D. M., Kaji, D. A., Sahoo, S., Hare, J. M., Hajjar, R. J., Sobie, E. A., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.310796 · Cited by 67
Oh, J. S., Kim, K. N., An, S. S., Pennant, W. A., Kim, H. J., Gwak, S., Yoon, D. H., Lim, M. H., Choi, B. H., & Ha, Y. S. (2010) · Cell Transplantation · doi:10.3727/096368910x539083 · Cited by 73
Therapeutic use of stem and endothelial progenitor cells in acute renal injury: ça ira
Patschan, D., Plotkin, M. D., & Goligorsky, M. S. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.10.013 · Cited by 72
Couto, B. G., Goldenberg, R. C. D. S., da Fonseca, L. M. B., Thomas, J., Gutfilen, B., Resende, C. M. C., Azevedo, F., Mercante, D. R., Torres, A. L. M., Coelho, H. S. M., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2010.02424.x · Cited by 67
Apatzidou, D. A., Bakopoulou, A., Kouzi‐Koliakou, K., Karagiannis, V., & Konstantinidis, A. (2021) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13474 · Cited by 73
Crisostomo, P. R., Abarbanell, A. M., Wang, M., Lahm, T., Wang, Y., & Meldrum, D. R. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00236.2008 · Cited by 66
Wang, H., Wáng, Y. X. J., Leung, K. C., Au, D. W. T., Xuan, S., Chak, C., Lee, S. K. M., Sheng, H., Zhang, G., Qin, L., et al. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200901548 · Cited by 66
Multipotent Stromal Cell Therapy for Cavernous Nerve Injury-Induced Erectile Dysfunction
Albersen, M., Kendirci, M., der Aa, F. V., Hellstrom, W. J. G., Lue, T. F., & Spees, J. L. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02556.x · Cited by 68
Yagi, H., Parekkadan, B., Suganuma, K., Soto–Gutiérrez, A., Tompkins, R. G., Tilles, A. W., & Yarmush, M. L. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0681 · Cited by 72
Therapeutic Effects of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Disease
Suzuki, E., Fujita, D., Takahashi, M., Oba, S., & Nishimatsu, H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4397-0_12 · Cited by 67
Davies, O. G., Cox, S. C., Williams, R. L., Tsaroucha, D., Dorrepaal, R. M., Lewis, M. P., & Grover, L. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-13027-6 · Cited by 71
Liu, H., Sun, X., Gong, X., & Wang, G. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28705 · Cited by 65
Abi3bp Is a Multifunctional Autocrine/Paracrine Factor that Regulates Mesenchymal Stem Cell Biology
Hodgkinson, C. P., Naidoo, V., Patti, K. G., Gómez, J. A., Schmeckpeper, J., Zhang, Z., Davis, B. H., Pratt, R. E., Mirotsou, M., & Dzau, V. J. (2013) · Stem Cells · doi:10.1002/stem.1416 · Cited by 68
Self-citationMicroencapsulated Stem Cells for Tissue Repairing: Implications in Cell-Based Myocardial Therapy
Paul, A., Ge, Y., Prakash, S., & Shum‐Tim, D. (2009) · Regenerative Medicine · doi:10.2217/rme.09.43 · Cited by 69
Haider, T. T., Höftberger, R., Rüger, B. M., Mildner, M., Blumer, R., Mitterbauer, A., Buchacher, T., Sherif, C., Altmann, P., Redl, H. R., et al. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.03.013 · Cited by 64
“In recent years, researchers have found that paracrine factors secreted by stem cellsmediate the observed beneficial effects of cell therapy (Gnecchi et al., 2005; Mirotsou et al., 2011; Teixeira et al., 2013).”
Multifunctional role of microRNAs in mesenchymal stem cell-derived exosomes in treatment of diseases
Xu, H., Chen, L., Zhou, S., Li, Y., & Xiang, C. C. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i11.1276 · Cited by 64
Stem Cell Sources for Regenerative Medicine
Riazi, A. M., Kwon, S. Y., & Stanford, W. L. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-060-7_5 · Cited by 78
Paracrine effects of mesenchymal stem cells on the activation of keratocytes
Jiang, Z., Liu, G., Meng, F., Wang, W., Hao, P., Xiang, Y., Wang, Y., Han, R., Li, F., Wang, L., et al. (2017) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2016-310012 · Cited by 64
Ghasemi, M., Roshandel, E., Mohammadian, M., Farhadihosseinabadi, B., Akbarzadehlaleh, P., & Shamsasenjan, K. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03264-0 · Cited by 74
“The main pathological features in both fAD and sAD are chronic accumulation of amyloid-beta (Aβ) plaque and neurofibrillary tangles (NFT) enriched by hyperphosphorylated protein tau [74].”
BackgroundSato, T., Iso, Y., Uyama, T., Kawachi, K., Wakabayashi, K., Omori, Y., Soda, T., Shoji, M., Koba, S., Yokoyama, S., et al. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2010.202 · Cited by 64
Cell-based Therapy for Heart Disease: A Clinically Oriented Perspective
Menasché, P. (2009) · Molecular Therapy · doi:10.1038/mt.2009.40 · Cited by 66
Torrente, D., Avila, M., Cabezas, R., Morales, L., González, J., Samudio, I. J., & Barreto, G. E. (2013) · Human & Experimental Toxicology · doi:10.1177/0960327113509659 · Cited by 66
“hMSC-CM, as like other mediums, contains some trophic factors that might interfere with some cellular functions.(20,42) Despite this caveat, we tested low hMSC-CM concentrations (2%), which contains approximately 0.”
BackgroundSivasami, P., Jayarajan, V., & Rose, C. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.01.014 · Cited by 72
“This observation is supported by the earlier findings that activated myofibroblasts are inhibited by MSC in vitro [30] and this inhibitionwas found to occur through the paracrine mechanism[31].”
ResultBraun, T. W., & Borchardt, T. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-02-0153 · Cited by 63
Landázuri, N., Levit, R. D., Joseph, G., Ortega‐Legaspi, J. M., Flores, C. A., Weiss, D., Sambanis, A., Weber, C. J., Safley, S. A., & Taylor, W. R. (2012) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1680 · Cited by 66
“…been purported to act in a paracrine manner to preserve tissue integrity and function after ischaemia (Kinnaird et al., 2004a, 2004b; Rehman et al., 2004; Aggarwal and Pittenger, 2005; Gnecchi et al., 2005; Caplan and Dennis, 2006; Copland et al., 2008; Uccelli et al., 2008; Armiñán et al., 2010).”
BackgroundStem cell-derived exosomes as a therapeutic tool for cardiovascular disease
Suzuki, E., Fujita, D., Takahashi, M., Oba, S., & Nishimatsu, H. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i9.297 · Cited by 65
Amponsah, P. S., Fan, P., Bauer, N., Zhao, Z., Gladkich, J., Fellenberg, J., & Herr, I. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.035 · Cited by 63
Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI
Shintani, S., Kusano, K. F., Ii, M., Iwakura, A., Heyd, L., Curry, C., Wecker, A., Gavin, M., Ma, H., Kearney, M., et al. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0430 · Cited by 64
Mesenchymal Stem Cells for Myocardial Infarction: Promises and Pitfalls
Wollert, K. C., & Drexler, H. (2005) · Circulation · doi:10.1161/circulationaha.105.551895 · Cited by 71
Leclerc, T., Thépenier, C., Jault, P., Bey, E., Peltzer, J., Trouillas, M., Duhamel, P., Bargues, L., Prat, M., Bonderriter, M., et al. (2011) · Cell Proliferation · doi:10.1111/j.1365-2184.2010.00727.x · Cited by 63
Di, R., Wu, X., Chang, Z., Zhao, X., Feng, Q., Lu, S., Luan, Q., Hemmings, B. A., Li, X., & Yang, Z. (2011) · Biochemical Journal · doi:10.1042/bj20110033 · Cited by 68
Song, M., Jue, S., Cho, Y., & Kim, E. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23569 · Cited by 62
“hMSCs are an attractive target for the treatment of neurological disorders because of their neuroprotective properties and limited immunogenicity (Gnecchi et al., 2005).”
BackgroundTeixeira, L. M., Georgi, N., Leijten, J., Wu, L., & Karperien, M. (2011) · Endocrine development · doi:10.1159/000328140 · Cited by 62
Lin, N., Hu, K., Chen, S., Xie, S., Tang, Z., Lin, J., & Xu, R. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.06.007 · Cited by 61
Mesenchymal Stem Cells Ameliorate Atherosclerotic Lesions via Restoring Endothelial Function
Lin, Y., Yet, S., Hsu, Y., Wang, G., & Hung, S. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0091 · Cited by 61
The Role of Mitochondria in Stem Cell Biology
Nesti, C., Pasquali, L., Vaglini, F., Siciliano, G., & Murri, L. (2007) · Bioscience Reports · doi:10.1007/s10540-007-9044-1 · Cited by 61
“…if it may partially explain the beneficial effects registered after either in vivo mobilization of mesenchimal stem cells or administration of large numbers of hMSCs in animal models of spinal cord injury, stroke and heart disease (Hofstetter et al. 2002; Chen et al. 2003; Gnecchi et al. 2005).”
BackgroundLi, F., Wang, X., & Niyibizi, C. (2010) · Bone · doi:10.1016/j.bone.2010.05.040 · Cited by 62
“The present findings are consistent with current concepts that stromal cells secrete factors that modulate microenvironments for tissue repair [6,39–42].”
ResultMultipotent adult progenitor cells: their role in wound healing and the treatment of dermal wounds
Herdrich, B. J., Lind, R. C., & Liechty, K. W. (2008) · Cytotherapy · doi:10.1080/14653240802345820 · Cited by 63
Hong, L., Long, Y., Xin, Z., Hao, J., Liu, W., Wang, S., Liao, S., Wang, H., & Yang, X. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz105 · Cited by 71
“MSCs have been shown to treat disease by secreting paracrine mediators, including cargo mRNAs, microRNAs, and proteins (Kinnaird et al., 2004; Gnecchi et al., 2005; Timmers et al., 2007; Curley et al., 2012).”
BackgroundSee, F., Seki, T., Psaltis, P. J., Sondermeijer, H. P., Gronthos, S., Zannettino, A. C. W., Govaert, K. M., Schuster, M., Kurlansky, P. A., Kelly, D. J., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01241.x · Cited by 61
“Moreover, injection of MSC-derived factors to the post-MI heart has been shown to rapidly promote angiogenesis and cardioprotection [7, 29–31].”
BackgroundFrost, R. J. A., & Engelhardt, S. (2007) · Circulation · doi:10.1161/circulationaha.107.696468 · Cited by 59
Liu, Y., & Holmes, C. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.648098 · Cited by 64
“For example, conditioned MSC culture media was found to have therapeutic effects similar to direct delivery of MSCs in rodent models (Gnecchi et al., 2005; Aslam et al., 2009).”
BackgroundMellows, B., Mitchell, R., Antonioli, M., Kretz, O., Chambers, D. J., Zeuner, M.-T., Denecke, B., Musante, L., Ramachandra, D. L., Debacq‐Chainiaux, F., et al. (2017) · Stem Cells and Development · doi:10.1089/scd.2017.0089 · Cited by 63
Metadata
- Authors
- Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., & Dzau, V. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Dzau, Victor J
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-04
- Volume
- 11
- Issue
- 4
- Pages
- 367-368
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2067591094
- Cited by
- 1,677
- References
- 7
- Citations by year
- 2026: 31 · 2025: 35 · 2024: 49 · 2023: 55 · 2022: 67 · 2021: 86 · 2020: 91 · 2019: 69 · 2018: 74 · 2017: 87 · 2016: 95 · 2015: 89 · 2014: 81 · 2013: 88 · 2012: 106
- FWCI
- 38.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- National Institutes of Health (1z01hl005320-01)
- National Heart, Lung, and Blood Institute (HL 73219, HL-58516, HL 72010, R01HL063985, HL 5320, R01HL058516, R01HL072010, HL-35610, R01HL073219, HL 63985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- paracrine signaling, mesenchymal stem cells, Akt signaling, myocardial ischemia, cardioprotection, cell therapy, exosomes, secretome
- MeSH terms
- Animals, Cells, Cultured, Myocardial Infarction, Myocardium, Proto-Oncogene Proteins, Cell Hypoxia, Bone Marrow Transplantation, Culture Media, Conditioned, Apoptosis, Protein Serine-Threonine Kinases, Intercellular Signaling Peptides and Proteins, Mesenchymal Stem Cell Transplantation, Green Fluorescent Proteins, Proto-Oncogene Proteins c-akt, Rats, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.